Edition:
United Kingdom

Constellation Pharmaceuticals Inc (CNST.OQ)

CNST.OQ on NASDAQ Stock Exchange Global Select Market

7.07USD
19 Oct 2018
Change (% chg)

$-0.05 (-0.70%)
Prev Close
$7.12
Open
$7.17
Day's High
$7.32
Day's Low
$7.05
Volume
2,677
Avg. Vol
--
52-wk High
$12.21
52-wk Low
$6.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.442
Mar '18 0.00 -0.448
FY 2017 Dec '17
Jun '17 0.00 -0.456
Mar '17 0.00 -0.365
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 3 -0.83 -0.74 -0.88 --
Quarter Ending Mar-19 1 -0.81 -0.81 -0.81 --
Year Ending Dec-18 2 -4.05 -3.80 -4.30 --
Year Ending Dec-19 4 -2.80 -2.51 -3.43 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.41 33.64
P/E High - Last 5 Yrs. -- 287.36 45.19
P/E Low - Last 5 Yrs. -- 89.75 23.75
Beta -- 0.93 0.88
Price to Sales (TTM) -- 124.37 5.83
Price to Book (MRQ) -- 15.29 4.89
Price to Tangible Book (MRQ) -- 14.52 6.51
Price to Cash Flow (TTM) -- 70.10 22.92
% Owned Institutions -- 14.25 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.40
Payout Ratio(TTM) -- 16.75 43.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.57 8.10
Sales (TTM) vs TTM 1 Yr. Ago -- 103.65 5.80
Sales - 5 Yr. Growth Rate -- 30.74 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 24.06 23.38
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 37.62 10.92
Capital Spending - 5 Yr. Growth Rate -- 38.52 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) -- 5.36 3.05
LT Debt to Equity (MRQ) -- 34.93 12.76
Total Debt to Equity (MRQ) -- 36.74 17.18
Interest Coverage (TTM) -- -96.75 37.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.09 54.87
Gross Margin - 5 Yr. Avg. -- 49.02 52.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -579.09 11.01
Operating Margin (TTM) -- -786.66 4.07
Operating Margin - 5 Yr. Avg. -- -600.20 6.34
Pre-Tax Margin (TTM) -- -748.77 5.12
Pre-Tax Margin - 5 Yr. Avg. -- -605.79 6.78
Net Profit Margin (TTM) -- -749.75 1.39
Net Profit Margin - 5 Yr. Avg. -- -608.47 3.03
Effective Tax Rate (TTM) -- 23.52 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,677,535 808,218,600
Net Income/Employee (TTM) -- 1,703,754 95,058,584
Receivable Turnover (TTM) -- 20.77 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) -- 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.39 10.90
Return on Assets - 5 Yr. Avg. -- 3.03 12.01
Return on Investment (TTM) -- 0.21 14.27
Return on Investment - 5 Yr. Avg. -- 2.10 15.60
Return on Equity (TTM) -- 1.17 15.99
Return on Equity - 5 Yr. Avg. -- 2.74 16.87

Performance for Constellation Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 58
13 Week -- -- -- 61
26 Week -- -- -- 76
52 Week -- -- -- 47
YTD -- -- -- 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 34.70%
# of Holders: 14
Total Shares Held: 8,923,903
3 Mo. Net Change: 8,923,903
# New Positions: 14
# Closed Positions: 0
# Increased Positions: 14
# Reduced Positions: 0
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.